arrow
I

Isabel Machuca

Reina Sofía University Hospital
H指数:27
被引数:2,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical-Microbiological Discordance and Delayed Mortality in OXA-48/ESBL-Producing Proteus mirabilis Infections

OXA-48/ESBL产生型奇异变形杆菌感染的临床-微生物学不匹配性及延迟死亡率

2026-10-060
OAAI
Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens

HIV感染者老年人群在更换为比克替格韦三联疗法或多替拉韦双联疗法后的生活质量

2026-09-170
PRE
Pneumocystis jirovecii prophylaxis with trimethoprim-sulfamethoxazole and resistance in ESBL-producing Enterobacterales bloodstream infections among kidney transplant recipients

肾移植受者中,使用甲氧苄啶-磺胺甲噁唑进行肺孢子菌肺炎预防与产超广谱β-内酰胺酶肠杆菌科细菌血流感染中的耐药性

2026-08-180
OAAI
Emerging Cross-Resistance to Cefiderocol and Ceftazidime-Avibactam in KPC-Producing Klebsiella pneumoniae During Ceftazidime-Avibactam Therapy

在头孢他啶-阿维巴坦治疗期间,产KPC肺炎克雷伯菌中出现的对费地ercolor和头孢他啶-阿维巴坦的交叉耐药性

2026-08-160
OA
Impact of CMV-specific immune reconstitution at the end of letermovir prophylaxis on the development of late cytomegalovirus infection in haematopoietic stem cell transplant recipients (INMUNOEND): a protocol for a prospective, observational, multicentre study

CMV特异性免疫重建在letermovir预防治疗结束时对造血干细胞移植受者晚期巨细胞病毒感染发展的影响(INMUNOEND):一项前瞻性、观察性、多中心研究的方案

2025-10-150
OA
Compassionate Use of Encapsulated MKB-01 Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: A Single-Center Experience

同情性使用封装的MKB-01粪菌移植治疗复发性Clostridioides difficile感染:一项单中心经验

2025-09-270
OAAI
Incidence, clinical and genomic trends of hospital- and Non-hospital-onset KPC-producing Klebsiella pneumoniae infections before and during the COVID-19 era: a ten-year interrupted time series study

医院获得与非医院获得产KPC型肺炎克雷伯菌感染在COVID-19时代前后的发病率、临床及基因组趋势:一项为期十年的中断时间序列研究

2025-08-250
PRE
Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

多药耐药革兰阴性杆菌感染在成年实体器官移植受者中的管理:GESITRA-IC/SEIMC、CIBERINFEC和SET指南更新。

2025-07-010
PRE
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3 noninferiority trial

西班牙低风险肺移植受者中免疫指导性巨细胞病毒疾病预防的安全性与有效性:一项多中心、开放标签、随机、III期非劣效性试验

2025-05-010
PRE
Quantifying Gamma-Interferon from CMV-Specific CD8+T Cells Defines Protection Against Clinically Significant CMV Infection in Solid Organ Transplant Recipients: The Quanti-CMV Score

通过定量CMV特异性CD8+T细胞中的γ-干扰素来定义实体器官移植受者临床显著CMV感染的防护作用:Quanti-CMV评分

2025-03-040
OA
Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital

抗菌药物管理计划对高流行医院耐碳青霉烯类肺炎克雷伯菌感染发生率的长期临床和生态影响

2024-08-231
OA
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
2022-12-260
PRE
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients

在定植患者的前瞻性队列中,肠道微生物群中产生KPC的肺炎克雷伯菌的相对负荷的预后意义

2022-08-315
OAAI
Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study

产碳青霉烯酶肺炎克雷伯菌直肠定植与死亡率的关系: 一项前瞻性观察性研究

2022-06-018
OAAI
Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients

住院患者肺炎克雷伯菌产碳青霉烯酶肺炎克雷伯菌感染的定植时机与发病风险的关系

2022-04-2710
OAAI